Wednesday, May 15, 2024

Wednesday, May 15, 2024

Organization Directory

Refine Your Search Health Care Drug Treatment Centers W

Type:

Filter by Org Category:

Filter By Name:


Trending

  1. 1 UROVANT SCIENCES: Announces U.S. FDA Approval of GEMTESA® (vibegron) 75 mg Tablets for the Treatment of Patients with Overactive Bladder (OAB)
FDA Health News